文献速递系统性红斑狼疮其他结缔组织病

系统性红斑狼疮骨髓衰竭的经验教训:病例报告与文献综述

Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.
PubMed 文献 · Semin Arthritis Rheum · 2017-12-08

本文报告4例系统性红斑狼疮(SLE)合并骨髓衰竭的新病例,并通过PubMed文献检索汇总31例自身免疫性骨髓纤维化(AIMF)、26例再生障碍性贫血(AA)和3例阵发性睡眠性血红蛋白尿(PNH)合并SLE的病例。结论认为SLE与骨髓衰竭的归因因缺乏生物标志物而具有挑战性;AIMF可能被低估,糖皮质激素和静脉注射免疫球蛋白似为有效的即刻治疗;AA归因于SLE时应检测血清骨髓前体抑制剂,因血浆置换在这些病例中普遍成功;持续溶血时应检测PNH克隆,因补体抑制可能有效。

要点

  • SLE与骨髓衰竭的归因缺乏生物标志物,使治疗决策复杂化。
  • AIMF可能被低估,糖皮质激素和静脉注射免疫球蛋白似为有效的即刻治疗。
  • AA归因于SLE时应检测血清骨髓前体抑制剂,因血浆置换在这些病例中普遍成功。

核心结论

  • SLE与骨髓衰竭的归因因缺乏生物标志物而具有挑战性,使治疗决策复杂化。
  • 自身免疫性骨髓纤维化可能被低估,但糖皮质激素和静脉注射免疫球蛋白似为有效的即刻治疗。
  • 在归因于SLE的AA中,应检测血清骨髓前体抑制剂,因血浆置换在这些病例中普遍成功。
  • 在持续溶血情况下应检测PNH克隆,因补体抑制可能有效。
  • 需要进一步研究以阐明SLE中骨髓衰竭的病理生理机制。

研究设计与样本

  • 本文报告4例新的骨髓衰竭病例并讨论SLE的可能贡献。
  • 通过PubMed进行布尔检索,交叉关键词「systemic lupus erythematosus」与「bone marrow fibrosis」「bone marrow failure」「myelofibrosis」「aplastic anemia」「paroxysmal nocturnal hemoglobinuria」。
  • 经严格选择既往有明确SLE诊断的病例后,综述汇总31例AIMF、26例AA和3例PNH病例。

主要发现

  • 综述汇总31例AIMF、26例AA和3例PNH合并SLE的病例。
  • 4例新病例说明将骨髓衰竭归因于SLE的困难。
  • AIMF可能被低估,糖皮质激素和静脉注射免疫球蛋白似为有效的即刻治疗。
  • 在归因于SLE的AA中,血浆置换在这些病例中普遍成功。
  • 在持续溶血情况下,补体抑制可能有效。

关键数值与推荐

  • 综述汇总31例AIMF、26例AA和3例PNH合并SLE的病例。
  • AIMF可能被低估,但糖皮质激素和静脉注射免疫球蛋白似为有效的即刻治疗。
  • 在归因于SLE的AA中,应检测血清骨髓前体抑制剂,因血浆置换在这些病例中普遍成功。
  • 在持续溶血情况下应检测PNH克隆,因补体抑制可能有效。

临床怎么用

  • 基于本文及既往病例的经验,提出了SLE中这些疾病的诊断和治疗策略。
  • 在归因于SLE的AA中,应检测血清骨髓前体抑制剂,因血浆置换在这些病例中普遍成功。
  • 在持续溶血情况下应检测PNH克隆,因补体抑制可能有效。
  • AIMF中糖皮质激素和静脉注射免疫球蛋白似为有效的即刻治疗。

局限性

  • SLE与骨髓衰竭的归因因缺乏生物标志物而具有挑战性,使治疗决策复杂化。
  • 自身免疫性骨髓纤维化可能被低估。
  • 需要进一步研究以阐明SLE中骨髓衰竭的病理生理机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the present review, four new cases of bone marrow failure are presented and the potential contribution of systemic lupus erythematosus (SLE) is discussed. Furthermore, a comprehensive literature review of cases of autoimmune myelofibrosis (AIMF), aplastic anemia (AA), and paroxysmal nocturnal hemoglobinuria (PNH) with concurrent SLE aims to allow their direct comparison. Based on a clearer characterization of reported cases and our own experience, diagnostic and therapeutic strategies of these disorders in SLE are proposed based on lessons learned from the present and previous cases. METHODS: A literature search was done in PubMed, accessed via the National Library of Medicine PubMed interface (http://www.ncbi.nlm.nih.gov/pubmed). Using PubMed, a Boolean search of the literature was performed by crossing the keywords "systemic lupus erythematosus," AND ["bone marrow fibrosis" or "bone marrow failure" or "myelofibrosis" or "aplastic anemia" or "paroxysmal nocturnal hemoglobinuria"]. RESULTS: After a stringent selection of previous cases with a clear diagnosis of SLE, we summarized in the present review 31 cases of AIMF, 26 cases of AA, and 3 cases of PNH. In addition, four new cases illustrate the problem of attribution of bone marrow failure to SLE. CONCLUSIONS: The attribution of SLE to bone marrow failure is challenging due to a lack of biomarkers, which complicates treatment decisions. Autoimmune myelofibrosis is likely underreported, but corticosteroids and intravenous immunoglobulin appear to be effective immediate therapies. In AA attributable to SLE, a serum inhibitor of bone marrow precursors should be tested, since plasma exchange has been universally successful in these cases, and a PNH clone should be tested for in the setting of ongoing hemolysis, as complement inhibition may be effective. Further research is warranted to elucidate pathophysiological mechanisms of bone marrow failure in SLE.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Anderson E, Shah B, Davidson A, et al. Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature. Semin Arthritis Rheum. 2017. PMID: 29395255. doi:10.1016/j.semarthrit.2017.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。